BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35394853)

  • 21. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects following COVID-19 vaccination in Iran.
    Babaee E; Amirkafi A; Tehrani-Banihashemi A; SoleimanvandiAzar N; Eshrati B; Rampisheh Z; Asadi-Aliabadi M; Nojomi M
    BMC Infect Dis; 2022 May; 22(1):476. PubMed ID: 35585518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral Panuveitis Mimicking Vogt-Koyanagi-Harada Disease following the First Dose of ChAdOx1 nCoV-19 Vaccine.
    Kim SY; Kang MS; Kwon HJ
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1218-1221. PubMed ID: 35113750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multisystem Inflammatory Syndrome in Adults (MIS-A) After COVID-19 Infection and Recent Vaccination with Recombinant Adenoviral Vector Encoding the Spike Protein Antigen of SARS-CoV-2 (ChAdOx1 nCoV-19, Vaxzevria).
    Ehikhametalor K; Deans-Minott J; Duncan JP
    J Intensive Care Med; 2023 Feb; 38(2):232-237. PubMed ID: 35979616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.
    Jantarabenjakul W; Chantasrisawad N; Puthanakit T; Wacharapluesadee S; Hirankarn N; Ruenjaiman V; Paitoonpong L; Suwanpimolkul G; Torvorapanit P; Pradit R; Sophonphan J; Putcharoen O
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):269-277. PubMed ID: 34717527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral Atypical Optic Neuritis following ChAdOx1_nCoV-19 Vaccination: A Putative Plausibility.
    Saluja P; Kohli GM; More A; Shetty SB; Sen A
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1250-1253. PubMed ID: 36256905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2.
    Pattni K; Hungerford D; Adams S; Buchan I; Cheyne CP; García-Fiñana M; Hall I; Hughes DM; Overton CE; Zhang X; Sharkey KJ
    BMC Infect Dis; 2022 Mar; 22(1):270. PubMed ID: 35307024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant).
    Job AM; Sudhamani B; Mohan M; Mohanasundaram SN
    Indian J Public Health; 2022; 66(1):83-85. PubMed ID: 35381724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of a severe bilateral pulmonary embolism as a complication of VITT following vaccination with AstraZeneca COVID-19 vaccine.
    Elkoumy M; Schoen J; Loew A
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35545306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune-mediated necrotizing myopathy following vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine: A case report and brief review.
    Ansari B; Najafi MA; Kheradmand M; Najafi F; Najafi MR
    Rev Neurol (Paris); 2023 Jun; 179(6):630-635. PubMed ID: 36754672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orbital myositis and scleritis after anti-SARS-CoV-2 mRNA vaccines: A report of three cases.
    Savino G; Gambini G; Scorcia G; Comi N; Fossataro C; Stanislao Rizzo
    Eur J Ophthalmol; 2023 Sep; 33(5):NP29-NP34. PubMed ID: 36062603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis.
    Anderson A; Seddon M; Shahzad K; Lunevicius R
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34876440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: "IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19".
    Hočevar A; Tomšič M
    Autoimmun Rev; 2022 Feb; 21(2):102989. PubMed ID: 34740853
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
    Havervall S; Marking U; Greilert-Norin N; Ng H; Gordon M; Salomonsson AC; Hellström C; Pin E; Blom K; Mangsbo S; Phillipson M; Klingström J; Hober S; Nilsson P; Åberg M; Thålin C
    EBioMedicine; 2021 Aug; 70():103523. PubMed ID: 34391088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scleritis and Episcleritis following Coronavirus Disease (COVID-19) Vaccination.
    Sanjay S; Handa A; Kawali A; Shetty R; Bhakti Mishra S; Mahendradas P
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1184-1190. PubMed ID: 36884356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central retinal vein occlusion post-COVID-19 vaccination.
    Sonawane NJ; Yadav D; Kota AR; Singh HV
    Indian J Ophthalmol; 2022 Jan; 70(1):308-309. PubMed ID: 34937265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi.
    Pichi F; Aljneibi S; Neri P; Hay S; Dackiw C; Ghazi NG
    JAMA Ophthalmol; 2021 Oct; 139(10):1131-1135. PubMed ID: 34473209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.